This session will introduce Tele-Harm Reduction (THR) as a crucial and innovative tool towards ending the HIV epidemic. THR leverages telehealth technology to deliver comprehensive care within syringe services programs (SSPs). T-SHARP is a clinical trial that aims to improve HIV outcomes among people who inject drugs (PWID). The trial evaluates the efficacy of this telehealth intervention in achieving viral suppression, initiating medications for opioid use disorder (MOUD), and curing hepatitis C. By bridging the digital divide and meeting PWID where they are, T-SHARP seeks to transform HIV care delivery and improve clinical outcomes.
Learning Objectives:
Learners will be able to:
Recognize and describe the comprehensive Tele-Harm Reduction (THR) as an intervention for rapid initiation of buprenorphine treatment, HIV medication (antiretroviral therapy), and hepatitis C treatment for people who inject drugs
.jpg "Teresa A. Chueng, MD, MPH photo")
